Xanthohumol: Mechanistic Actions and Emerging Evidence as a Multi-Target Natural Nutraceutical

Area of Science:

• Natural Product Chemistry
• Pharmacology
• Translational Medicine

Background:

• Xanthohumol (XN) is a prenylated chalcone flavonoid found in hops (Humulus lupulus).
• It is recognized for its diverse biological activities and potential therapeutic applications.

Purpose of the Study:

• To elucidate the mechanistic hierarchy of Xanthohumol (XN).
• To explore its translational relevance across various disease areas, including cancer, metabolic, neurological, cardiovascular, hepatic, renal, and dermatological disorders.

Main Methods:

• A comprehensive and integrative literature review was conducted.
• The review focused on biological and translational effects of XN.

Main Results:

• XN inhibits pro-oncogenic and pro-inflammatory pathways (e.g., NF-κB, PI3K/Akt/mTOR) and activates cytoprotective pathways (e.g., Nrf2/ARE, AMPK).
• It demonstrates anticancer activity in preclinical models and exhibits multi-organ protective effects, including antioxidant, anti-inflammatory, and neuroprotective properties.
• Human studies indicate XN is safe and well-tolerated, reducing oxidative DNA damage and inflammatory markers. Improved formulations enhance its bioavailability.

Conclusions:

• Xanthohumol (XN) is a safe, multifunctional natural compound with significant potential for modulating disease pathways.
• Its therapeutic applications span cancer, neurodegenerative diseases, metabolic disorders, and inflammatory skin conditions.
• Enhancing bioavailability and conducting clinical trials are crucial for its clinical translation.